Otc - Active Ingredient
TEA TREE OIL、SALIX ALBA BARK、ANGELICA SINENSIS ROOT
South Moon Multi-purpose Nail Solution Liquid
FDA Label NDC 84983-008
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shantou South Moon Biotechnology Co., Ltd. for the product South Moon Multi-purpose Nail Solution (NDC 84983-008). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - when using, otc - purpose, otc - stop use, otc - do not use, otc - keep out of reach of children, storage and handling, warnings, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - When Using
1. Clean and dry the nails and surrounding skin.
2. Use a nail file to gently shape the nails.
3. Take an appropriate amount of this product and drop it on the nails.
4. Gently massage with fingertips to absorb.
Otc - Purpose
1. Highly effective care, gentle use.
2. Precise penetration, improved appearance.
3. Strengthen nail health, nourish and moisturize.
4. Gentle formula, suitable for sensitive skin.
Otc - Stop Use
Discontinue use if signs of irritation or rash occur.
Otc - Do Not Use
Discontinue use if signs of irritation or rash occur.
Otc - Keep Out Of Reach Of Children
Please keep out of reach of children. Do not swallow.
Storage And Handling
Store in a cool and dry place.
Warnings
Please keep out of reach of children. Do not swallow.Please clean your hands before use to ensure the best results from the product. Discontinue use if signs of irritation or rash occur. Store in a cool and dry place.
Inactive Ingredient
WATER、UREA、SILVER CHLORIDE、GLYCERIN
Package Label.Principal Display Panel
.jpg "SO-A07-0018-01(1).jpg")
Label (So A07 0018 01(1))
* Please review the disclaimer below.
